CytoMed Therapeutics Refutes Misleading Claims and Reaffirms Clinical Progress

Go back to CytoMed Therapeutics Refutes Misleading Claims and Reaffirms Clinical Progress
(NASDAQ: GDTC) Delayed: 1.03 +0.13 (14.44%)
Previous Close $0.90    52 Week High
Open $0.80    52 Week Low
Day High $1.03    P/E N/A 
Day Low $0.80    EPS
Volume 59,836